Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jazz Pharmaceuticals
Bayer
Actuate Therapeutics Inc.
Hoffmann-La Roche
Psyence Australia Pty Ltd
University of Colorado, Denver
Daiichi Sankyo
HealthPartners Institute
UNC Lineberger Comprehensive Cancer Center
Mayo Clinic
Seagen Inc.
Tempus AI
Pfizer
OHSU Knight Cancer Institute
Memorial Sloan Kettering Cancer Center
Elevation Oncology
Optimal Health Research
Region Örebro County
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Exelixis
Universitair Ziekenhuis Brussel
Convalife (Shanghai) Co., Ltd.
pharmaand GmbH
Infinity Pharmaceuticals, Inc.
Hoffmann-La Roche
OncoNano Medicine, Inc.
Jules Bordet Institute
National Institutes of Health Clinical Center (CC)
Bayer
Wake Forest University Health Sciences
Abramson Cancer Center at Penn Medicine
Advanced Accelerator Applications
Sun Yat-sen University
Tetra Bio-Pharma
Cambridge University Hospitals NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
University of Maryland, Baltimore
City of Hope Medical Center
Stanford University
Washington University School of Medicine
Amgen
RenJi Hospital
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Massachusetts General Hospital
Duke University
Emory University